DreaMed Diabetes Granted FDA Authorisation to Offer Personalised Optimisation of Insulin Pump Therapy
DreaMed Diabetes, a developer of personalised diabetes management solutions, has been granted a De Novo request, by the FDA, for DreaMed Advisor Pro, an artificial…